Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie Chen

Showing results (81-90 of 214) with videos related to

Pageof 22
Sort By:
Future Oncology (London, England)|June 22, 2026
Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summaryHope S Rugo, Xianchen Liu, Benjamin Li, et al.
Pharmacogenetics and Genomics|March 16, 2006
Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humansMaria Bastaki, Karen Huen, Paolo Manzanillo, et al.
The Oncologist|October 17, 2024
Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectivenessAdam Brufsky, Xianchen Liu, Benjamin Li, et al.
Pigment Cell & Melanoma Research|May 11, 2012
SOX2 modulates levels of MITF in normal human melanocytes, and melanoma lines in vitroFlavio Cimadamore, Meera Shah, Alejandro Amador-Arjona, et al.
Pharmacoepidemiology and Drug Safety|October 27, 2007
Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawalMyrthe P P Sukel, Michiel W van der Linden, Connie Chen, et al.
The Clinical Journal of Pain|August 24, 2004
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trialTito R Mendoza, Connie Chen, Andrew Brugger, et al.
Pain|April 15, 2004
Lessons learned from a multiple-dose post-operative analgesic trialTito R Mendoza, Connie Chen, Andrew Brugger, et al.
Future Oncology (London, England)|March 22, 2024
Prolonging the lives of African-Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice: a plain language summary of a real-world database studyHope S Rugo, Xianchen Liu, Benjamin Li, et al.
Antioxidants (Basel, Switzerland)|January 25, 2025
Multicomponent Dietary Supplementation: Impact on Tear Secretion and Ocular Surface Inflammation in Dry Eye Syndrome PatientsShih-Chien Huang, Yen-Ping Lei, Min-Chien Hsiao, et al.
NPJ Vaccines|October 29, 2024
Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccinationJing-Xing Li, Yu-Hsun Wang, Henry Bair, et al.
Pageof 22

Showing results (81-90 of 214) with videos related to

Sort By:
Pageof 22
Future Oncology (London, England)|June 22, 2026
Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summaryHope S Rugo, Xianchen Liu, Benjamin Li, et al.
Pharmacogenetics and Genomics|March 16, 2006
Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humansMaria Bastaki, Karen Huen, Paolo Manzanillo, et al.
The Oncologist|October 17, 2024
Palbociclib plus aromatase inhibitors in patients with metastatic breast cancer and cardiovascular diseases: real-world effectivenessAdam Brufsky, Xianchen Liu, Benjamin Li, et al.
Pigment Cell & Melanoma Research|May 11, 2012
SOX2 modulates levels of MITF in normal human melanocytes, and melanoma lines in vitroFlavio Cimadamore, Meera Shah, Alejandro Amador-Arjona, et al.
Pharmacoepidemiology and Drug Safety|October 27, 2007
Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawalMyrthe P P Sukel, Michiel W van der Linden, Connie Chen, et al.
The Clinical Journal of Pain|August 24, 2004
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trialTito R Mendoza, Connie Chen, Andrew Brugger, et al.
Pain|April 15, 2004
Lessons learned from a multiple-dose post-operative analgesic trialTito R Mendoza, Connie Chen, Andrew Brugger, et al.
Future Oncology (London, England)|March 22, 2024
Prolonging the lives of African-Americans with metastatic breast cancer by adding palbociclib to an aromatase inhibitor in routine clinical practice: a plain language summary of a real-world database studyHope S Rugo, Xianchen Liu, Benjamin Li, et al.
Antioxidants (Basel, Switzerland)|January 25, 2025
Multicomponent Dietary Supplementation: Impact on Tear Secretion and Ocular Surface Inflammation in Dry Eye Syndrome PatientsShih-Chien Huang, Yen-Ping Lei, Min-Chien Hsiao, et al.
NPJ Vaccines|October 29, 2024
Reply to: mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccinationJing-Xing Li, Yu-Hsun Wang, Henry Bair, et al.
Pageof 22